SCHEMBL2788945

SCHEMBL2788945

Nc1ccc(C(F)(F)F)cc1S

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 3/20 0.47
PKM P14618 1/20 0.47
HPGD P15428 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
NOS3 P29474 1/20 0.43
NOS2 P35228 1/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
MAPT P10636 4/20 0.43
KIF11 P52732 3/20 0.43
GAA P10253 2/20 0.43
MEN1 O00255 1/20 0.43
GFER P55789 1/20 0.43
KMT2A Q03164 1/20 0.43
BACE1 P56817 1/20 0.42
CFTR P13569 1/20 0.42
RAB9A P51151 2/20 0.41
LMNA P02545 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30532274 1.00 ALDH1A1 (0.47) ALDH1A1KDM4EPKMHPGDHSD17B10
Hydrochloric Acid SCHEMBL4183751 0.98 ALDH1A1 (0.46) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL6757387 0.88 ALDH1A1 (0.37) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL14934147 0.85 ALDH1A1 (0.35) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL718187 0.85 ESR1 (0.40) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL11245521 0.81 AR (0.46) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL29697575 0.81 ALDH1A1 (0.52) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL657504 0.81 ALDH1A1 (0.52) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL29505675 0.80 ALDH1A1 (0.55) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL161784 0.80 ALDH1A1 (0.55) ALDH1A1KDM4EPKMHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4406957-B1 ARYL RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME NOGRA PHARMA LTD (IE) 2026-04-08 EP disclosed
US-12577256-B2 Aryl receptor modulators and methods of making and using the same NOGRA PHARMA LIMITED (IE) 2026-03-17 US disclosed
US-20250129063-A1 BENZOTHIAZOLE COMPOUNDS AS VHL LIGANDS GENENTECH, INC. (US) 2025-04-24 US disclosed
EP-4522270-A1 BENZOTHIAZOLE COMPOUNDS AS VHL LIGANDS Genentech Inc. (US) 2025-03-19 EP disclosed
US-20250066384-A1 ARYL RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME NOGRA PHARMA LIMITED (IE) 2025-02-27 US disclosed
EP-4406957-A2 ARYL RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME Nogra Pharma Limited (IE) 2024-07-31 EP disclosed
US-12012418-B2 Aryl receptor modulators and methods of making and using the same NOGRA PHARMA LIMITED (IE) 2024-06-18 US disclosed
US-20240132457-A1 3-(2-(BENZO[D]THIAZOL-2-YL)-2-(PHENYLSUFONAMIDO)ETHYL)BENZIMIDAMIDE DERIVATIVES AND RELATED COMPOUNDS AS TMPRSS2 INHIBITORS FOR THE TREATMENT OF VIRAL INFECTIONS INTEGERBIO, INC. 2024-04-25 US disclosed
EP-3160964-B1 ARYL RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME NOGRA PHARMA LTD (IE) 2024-03-13 EP disclosed
WO-2023220237-A1 BENZOTHIAZOLE COMPOUNDS AS VHL LIGANDS GENENTECH, INC. (US) 2023-11-16 WO disclosed
EP-0024016-B1 TETRACHLOROPHTHALAMIC ACIDS, PROCESS FOR THEIR PREPARATION AND THEIR BACTERICIDAL USE BAYER AG (DE) 1982-02-24 EP disclosed
EP-0003099-B1 N-PHENYL-N'(2-CHLORO-6-FLUORO-BENZOYL) UREA, PREPARATION THEREOF AND USE THEREOF AS INSECTICIDES BAYER AG (DE) 1981-09-16 EP disclosed
US-4277499-A Combating insects with N-(substituted-phenyl)-N-(2-chloro-6-fluoro-benzoyl)-ureas BAYER AKTIENGESELLSCHAFT (DE) 1981-07-07 US disclosed
US-4276310-A ARTHROPODICIDES, FUNGICIDES, BACTERICIDES BAYER AKTIENGESELLSCHAFT (DE) 1981-06-30 US disclosed
EP-0024016-A1 Tetrachlorophthalamic acids, process for their preparation and their bactericidal use BAYER AG (DE) 1981-02-18 EP disclosed
EP-0000156-B1 2-ARYLAMINO-3,5-DINITRO-BENZOTRIFLUORIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES. BAYER AG (DE) 1980-11-12 EP disclosed
EP-0008435-A2 Substituted N-phenyl-N'-benzoyl-thioureas, their preparation and their use as pesticides BAYER AG (DE) 1980-03-05 EP disclosed
EP-0003099-A2 N-phenyl-N'(2-chloro-6-fluoro-benzoyl) urea, preparation thereof and use thereof as insecticides BAYER AG (DE) 1979-07-25 EP disclosed
EP-0000156-A1 2-Arylamino-3,5-dinitro-benzotrifluorides, process for their preparation and their use as pesticides. BAYER AG (DE) 1979-01-10 EP disclosed
US-3984405-A PYRIDO(3,2-B)(1,4)OXAZIN-3(4H)-ONES E. R. SQUIBB & SONS, INC. (US) 1976-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577256-B2 Aryl receptor modulators and methods of making and using the same AHR, IL23R, ARNT ALDH1A1 2164/4885KDM4E 2605/4885PKM 3671/4885
US-20250066384-A1 ARYL RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME AHR, IFNAR1, IL23R ALDH1A1 948/4885KDM4E 3114/4885PKM 4375/4885
US-12012418-B2 Aryl receptor modulators and methods of making and using the same AHR, IL23R, IL2RA ALDH1A1 774/4885KDM4E 2908/4885PKM 4310/4885
US-20240132457-A1 3-(2-(BENZO[D]THIAZOL-2-YL)-2-(PHENYLSUFONAMIDO)ETHYL)BENZIMIDAMIDE DERIVATIVES AND RELATED COMPOUNDS AS TMPRSS2 INHIBITORS FOR THE TREATMENT OF VIRAL INFECTIONS TMPRSS2, TMPRSS4, TMPRSS11D ALDH1A1 1094/4885KDM4E 2856/4885PKM 589/4885
US-20250129063-A1 BENZOTHIAZOLE COMPOUNDS AS VHL LIGANDS VHL, BRCA1, GLS ALDH1A1 2210/4885KDM4E 1366/4885PKM 1044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.